Subfascial endoscopic perforator surgery (SEPS) for treating and preventing recurrence of venous leg ulcers

Lin, Zhiliang Caleb; Loveland, Paula; Johnston, Renea V; Bruce, Michael G.; Weller, Carolina

doi:10.1002/14651858.cd012164

Cited by 3 publications

(2 citation statements)

References 44 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…There is evidence to suggest that surgical obliteration of incompetent perforator veins may promote longer ulcer‐free periods and lower rates of recurrence, but the studies reported that the differences in compression and surgical groups were not statistically significant . A SR of the evidence of effectiveness of subfascial endoscopic perforator surgery for VLU treatment and prevention of recurrence is in progress …”

Section: Resultsmentioning

confidence: 99%

Adjuvant therapies in venous leg ulcer management: A scoping review

Team

Chandler

Weller

2019

Wound Repair Regeneration

View full text Add to dashboard Cite

Compression therapy is the current evidence-based approach to manage venous leg ulcers (VLU); however, adherence is a major barrier to successful treatment. Combination approaches may relieve the burden of treatment by shortening the time to ulcer healing. This scoping review conducted by Australian researchers aimed to establish the evidence of effectiveness of various adjuvant methods on wound healing and recurrence. Randomized Controlled Trials (RCTs), and Systematic Reviews (SR) and Meta-Analyses (MA) on VLU management approaches published from January 2015 to December 2018 were included in this review. The articles included in the scoping review were grouped according to the management approaches, including (1) pharmaceutical interventions, (2) surgical interventions, (3) topical agents, (4) the use of devices, and (5) other, such as physiotherapy and psychological interventions. Results of this scoping review indicate that there is a limited high-quality evidence of effectiveness in most adjuvant therapies on wound healing and recurrence. Given the lowquality evidence observed in this scoping review for adjuvant treatments, the implication for practice is that current management guidelines be followed. Further rigorous studies have the potential to produce better quality evidence. Quality of evidence can be improved by ensuring large sample sizes of a single etiology wounds, standardizing reporting outcomes, and maintaining detailed and evidence-based protocols in physiological or psychological interventions.

show abstract

Section: Resultsmentioning

confidence: 99%

Adjuvant therapies in venous leg ulcer management: A scoping review

Team

Chandler

Weller

2019

Wound Repair Regeneration

View full text Add to dashboard Cite

show abstract

“…The cost of care and management of VLU is high and as the population ages, associated healthcare costs will increase. Costs in the USA rose from $US 1 billion in the early 1990s to almost 15 billion in 2011 and costs in the UK are estimated at between £300 and £600 Million per year (Lin, Loveland, Johnston, Bruce, & Weller, ).…”

Section: Introductionmentioning

confidence: 99%